William Blair Reiterates Outperform Rating for Axon Enterprise (NASDAQ:AXON)

Axon Enterprise (NASDAQ:AXONGet Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at William Blair in a research note issued on Wednesday, RTT News reports.

A number of other research firms also recently issued reports on AXON. JMP Securities boosted their price target on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research note on Tuesday, February 6th. TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Finally, Robert W. Baird upped their target price on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $312.64.

Get Our Latest Report on Axon Enterprise

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $306.24 on Wednesday. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm has a market capitalization of $23.11 billion, a price-to-earnings ratio of 133.15 and a beta of 0.93. The company’s 50-day moving average is $302.78 and its two-hundred day moving average is $260.58. Axon Enterprise has a 1-year low of $175.37 and a 1-year high of $329.87.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. The business had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. Analysts forecast that Axon Enterprise will post 2.44 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. New York State Teachers Retirement System boosted its holdings in shares of Axon Enterprise by 0.4% in the 1st quarter. New York State Teachers Retirement System now owns 72,715 shares of the biotechnology company’s stock valued at $22,751,000 after buying an additional 262 shares in the last quarter. WCM Investment Management LLC boosted its stake in Axon Enterprise by 2.0% during the 1st quarter. WCM Investment Management LLC now owns 5,894 shares of the biotechnology company’s stock worth $1,844,000 after purchasing an additional 115 shares during the period. Ulland Investment Advisors LLC boosted its stake in Axon Enterprise by 0.4% during the 1st quarter. Ulland Investment Advisors LLC now owns 22,155 shares of the biotechnology company’s stock worth $6,932,000 after purchasing an additional 89 shares during the period. Schnieders Capital Management LLC acquired a new stake in Axon Enterprise during the 1st quarter worth $244,000. Finally, Aubrey Capital Management Ltd boosted its stake in Axon Enterprise by 3.3% during the 1st quarter. Aubrey Capital Management Ltd now owns 15,600 shares of the biotechnology company’s stock worth $4,881,000 after purchasing an additional 500 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.